section name header

Pronunciation ⬇

rye-ba-VYE-rin audio

Indications ⬆ ⬇

REMS

Action ⬆ ⬇

Therapeutic Effects:

Pharmacokinetics ⬆ ⬇

Absorption: Systemic absorption occurs following nasal and oral inhalation. Rapidly and extensively absorbed following oral administration, but undergoes first-pass hepatic metabolism (64% bioavailability).

Distribution: 70% of inhaled drug is deposited in the respiratory tract. Appears to concentrate in the respiratory tract and red blood cells. Enters breast milk.

Metabolism/Excretion: Eliminated from the respiratory tract by distribution across membranes, macrophages, and ciliary motion. Metabolized primarily by the liver; metabolites are renally excreted.

Half-life: Inhaln — 9.5 hr (40 days in RBCs); oral — 43.6 hr (single dose); 12 days (multiple dose).

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Inhalation

CV: CARDIAC ARREST, hypotension.

Derm: rash.

EENT: blurred vision, conjunctivitis, erythema of the eyelids, ocular irritation, photosensitivity.

Hemat: hemolytic anemia, reticulocytosis.

Oral

CNS: HOMICIDAL IDEATION, SUICIDAL IDEATION/ATTEMPTS, depression, aggressive behavior, emotional lability (↑ in children), fatigue (↓ in children), impaired concentration (↓ in children), insomnia (↓ in children), irritability (↓ in children).

Derm: pruritus (↓ in children).

EENT: dry mouth, optic neuritis, papilledema, retinal artery/vein thrombosis, retinal detachment, retinal hemorrhage, retinopathy (with macular edema), visual abnormalities.

GI: anorexia (↑ in children), dyspepsia (↓ in children), vomiting (↑ in children).

GU: ↓fertility (males).

Hemat: hemolytic anemia.

MS: arthralgia (↓ in children).

Neuro: dizziness, faintness.

Resp: dyspnea (↓ in children).

Misc: fever (↑ in children).

Interactions ⬆ ⬇

Drug-Drug:

Route/Dosage ⬆ ⬇

RSV Infection

Chronic Hepatitis C

Viral Genotype 1 or 4

Renal Impairment

Renal Impairment

Implementation ⬆ ⬇

US Brand Names ⬆ ⬇

Copegus, Rebetol, Virazole

Canadian Brand Names ⬆ ⬇

Ibavyr

Classifications ⬆ ⬇

Therapeutic Classification: antivirals

Pharmacologic Classification: nucleoside analogues

Availability ⬆ ⬇

(Generic available)

Time/Action Profile ⬆ ⬇

(blood levels)

ROUTEONSETPEAKDURATION
Inhalnunknownend of inhalnunknown
POunknown1.7–3 hr12 hr

Assessment ⬆ ⬇

Lab Test Considerations:

Pot. Nursing Diagnoses ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

Code ⬆

NDC Code*